Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Hologic (NASDAQ: HOLX) and Express Scripts (NASDAQ: ESRX)

By Ryan Adsit

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (NYSE: ABBV), Hologic (NASDAQ: HOLX) and Express Scripts (NASDAQ: ESRX) with bullish sentiments.

AbbVie (NYSE: ABBV)

In a report issued on May 25, Jeffrey Holford from Jefferies reiterated a Buy rating on AbbVie (NYSE: ABBV), with a price target of $90. The company’s shares closed yesterday at $66.06, close to its 52-week high of $68.12.

According to TipRanks.com, Holford is a 5-star analyst with an average return of 8.4% and a 73.2% success rate. Holford covers the Healthcare sector, focusing on stocks such as Parnell Pharmaceuticals, Johnson & Johnson, and Sanofi-Aventis Sa.

AbbVie has an analyst consensus of Moderate Buy, with a price target consensus of $76.07.

Hologic (NASDAQ: HOLX)

Jefferies analyst Steven Desanctis reiterated a Buy rating on Hologic (NASDAQ: HOLX) yesterday and set a price target of $49. The company’s shares closed yesterday at $43.35.

According to TipRanks.com, Desanctis is a 1-star analyst with an average return of -0.8% and a 42.3% success rate. Desanctis covers the Basic Materials sector, focusing on stocks such as Southwestern Energy, Pioneer Natural, and Albemarle Corp.

Currently, the analyst consensus on Hologic is Strong Buy and the average price target is $48.50, representing an 11.9% upside.

In a report issued on May 11, Needham also reiterated a Buy rating on the stock with a $50 price target.
Express Scripts (NASDAQ: ESRX)

Jefferies analyst Brian Tanquilut reiterated a Buy rating on Express Scripts (NASDAQ: ESRX) yesterday and set a price target of $67. The company’s shares closed yesterday at $59.76, close to its 52-week low of $57.80.

According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 3.0% and a 52.0% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals, Five Star Quality Care, and Quest Diagnostics Inc.

Express Scripts has an analyst consensus of Moderate Buy, with a price target consensus of $64.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.